Compare ONCY & NTIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ONCY | NTIC |
|---|---|---|
| Founded | 1998 | 1970 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Industrial Specialties |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.7M | 83.1M |
| IPO Year | 2002 | 1996 |
| Metric | ONCY | NTIC |
|---|---|---|
| Price | $0.94 | $8.85 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $7.33 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 10.8K |
| Earning Date | 05-08-2026 | 04-09-2026 |
| Dividend Yield | N/A | ★ 0.49% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $84,234,474.00 |
| Revenue This Year | N/A | $12.49 |
| Revenue Next Year | $2,505.00 | $7.64 |
| P/E Ratio | ★ N/A | $441.50 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.71 | $7.14 |
| 52 Week High | $1.51 | $10.03 |
| Indicator | ONCY | NTIC |
|---|---|---|
| Relative Strength Index (RSI) | 52.82 | 82.04 |
| Support Level | $0.90 | $8.55 |
| Resistance Level | $1.06 | $9.00 |
| Average True Range (ATR) | 0.06 | 0.17 |
| MACD | 0.01 | 0.09 |
| Stochastic Oscillator | 62.80 | 100.00 |
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.
Northern Technologies International Corp is a United States-based firm that develops and markets proprietary, environmentally beneficial products and services world wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments, which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company. The company generates the majority of its revenue in the United States.